Therapeutic applications of Hypericum perforatum (St. John’s wort) for treating anxiety and depression

integrative review

Authors

DOI:

https://doi.org/10.56102/afmo.2023.252

Keywords:

Anxiety, Depression, Phytopharmaceuticals, Hypericum perforatum

Abstract

Hypericum perforatum, known as St. John’s wort, is a popular medicinal plant recom mended in traditional Chinese medicine and prescribed for depression in European coun tries. However, conflicting data were observed regarding its benefits and risks. This study aimed to evaluate phytopharmaceuticals containing Hypericum perforatum extracts for anxiety and depression treatment. An integrative review was performed by searching Literatura Latino-Americana e do Caribe em Saúde (LILACS), Scientific Electronic Library Online (SciELO), and Publisher Medline (PubMed) databases and included studies in Portuguese, English, and Spanish from 2017 to 2022. Randomized clinical trials confirmed the efficacy of the Hypericum perforatum extracts compared with placebo on mild and moderately severe depression. Further randomized controlled studies demonstrated similar efficacy to conventional antidepressants for anxiety and mild to moderate depression. The study concludes the need for more studies to evaluate the efficacy of Hypericum perforatum extracts, especially concerning adverse effects, risks, and drug interactions.

Author Biographies

Alany Lima Soares Chagas, Faculdade de Medicina de Olinda

Student at the Faculdade de Medicina de Olinda. Olinda, Pernambuco, Brazil.

Heloise Gabriella Queiroz Moura, Faculdade de Medicina de Olinda

Student at the Faculdade de Medicina de Olinda. Olinda, Pernambuco, Brazil.

Klyvia Renaly Brayner de Sá, Faculdade de Medicina de Olinda

Student at the Faculdade de Medicina de Olinda. Olinda, Pernambuco, Brazil.

Laila Caroline Duarte Nascimento, Faculdade de Medicina de Olinda

Student at the Faculdade de Medicina de Olinda. Olinda, Pernambuco, Brazil.

Larissa Cândida Pereira Guedes, Faculdade de Medicina de Olinda

Student at the Faculdade de Medicina de Olinda. Olinda, Pernambuco, Brazil.

Priscyla Gonçalves Pinheiro Moura, Faculdade de Medicina de Olinda

Student at the Faculdade de Medicina de Olinda. Olinda, Pernambuco, Brazil.

Tharcia Kiara da Cruz, Faculdade de Medicina de Olinda

Doutora em Engenharia Agrícola pela Universidade Federal de Campina Grande - UFCG; Mestre em Engenharia Agrícola na Área de Processamento e Armazenamento de Produtos Agrícolas; Especialização em Auditoria em Saúde pelo Centro de Ensino Superior e Desenvolvimento - CESED; Graduação em Medicina Veterinária pela UFCG. Professora da Faculdade de Medicina de Olinda - FMO e do Centro Universitário UNIFACISA. Tem experiência na área de Medicina Veterinária, atuando principalmente no seguinte tema: Biotério, Produtos e Processos Aplicados a Alimentos, Animais de Laboratório, Ética e Bem-Estar Animal. Olinda, Pernambuco, Brasil.

References

Agapouda A, Booker A, Kiss T, Hohmann J, Heinrich M, Csupor D. Quality control of Hypericum perforatum L. analytical challenges and recent progress. Journal of Pharmacy and Pharmacology, 2019; 71(1): 15-37.

Amorim MCM, Reis BV, Batista F, Silva LM, Matos M, Souza VJO, Cunha MF. Desenvolvimento de líquido oral para veicular a associação de Hypericum perforatum L e Passiflora Incarnata L. Revista Pesquisa e Ação, 2017; 3(1).

Ramos SM, Martín OR, Docando YG, Pérez DD, López JRG, García MÁ. El Hypericum perforatum como anestésico local en las extracciones dentarias. Mediciego, 2017; 22(1): 31-36.

Hasenclever L, Paranhos J, Costa CR, Cunha G, Vieira D. A indústria de fitoterápicos brasileira: desafios e oportunidades. Ciência & Saúde Coletiva, 2017; 22(8): 2559-2569.

Prado MAS, Matsuok JT, Giotto AC. Importância das Farmácias Vivas no âmbito da produção dos medicamentos fitoterápicos. Revista de Iniciação Científica e Extensão, 2018; 1(1): 32-37.

Barnes J, Arnason JT, Roufogalis BD. St John's wort (Hypericum perforatum L.): botanical, chemical, pharmacological and clinical advances. Journal of Pharmacy and Pharmacology, 2019; 71(1): 1-3.

Chrubasik-Hausmann S, Vlachojannis J, McLachlan AJ. Understanding drug interactions with St John's wort (Hypericum perforatum L.): impact of hyperforin content. Journal of Pharmacy and Pharmacology, 2019; 71(1): 129-138.

Forsdike K, Pirotta M. St John's wort for depression: scoping review about perceptions and use by general practitioners in clinical practice. Journal of Pharmacy and Pharmacology, 2019; 71(1): 117-128.

Galeotti N. Hypericum perforatum (St John's wort) beyond depression: A therapeutic perspective for pain conditions. Journal of ethnopharmacology, 2017; 1(200): 136-146.

Nunes A. Utilização da planta medicinal erva-de-são-joão (Hypericum perforatum L.) no tratamento de depressão. Visão Acadêmica, 2018; 19(3).

Okmen G, Balpınar N. The biological activities of Hypericum perforatum L. African Journal of Traditional, Complementary and Alternative Medicines, 2017; 14(1): 213-218.

Bortoluzzi MM, Schmitt V, Mazur CE. Efeito fitoterápico de plantas medicinais sobre a ansiedade: uma breve revisão. Research, Society and Development, 2020; 9(2): 47.

Silva ELP, Soares JCF, Machado MJ, Reis IMA, Cova SC. Avaliação do perfil de produção de fitoterápicos para o tratamento de ansiedade e depressão pelas indústrias farmacêuticas brasileiras. Brazilian Journal of Development, 2020; 6(1): 3119-3135.

Volz HP. Hypericum and Depression. NeuroPsychopharmacotherapy, 2020; 1(1): 1-8.

Adibelli Z, Karacay I, Demir M, Duran C. St. John’s Wort (Hypericum perforatum)-Related Acute Kidney Injury. Blood Purification, 2022; 51(6): 520-522.

Tomova V, Pavlov I, Ivanova N. Evaluation of the Effectiveness and Mechanism of Action of Hypericum Perforatum in the Treatment of Depressive Disorders. Scripta Scientifica Vox Studentium, 2017; 1(1): 1-10.

Mascarenhas JM, Rodrigues JLG. Hypericum perforatum L. (Erva-De-São-João) no tratamento da depressão: uma revisão bibliográfica. Revista Ibero-Americana de Humanidades, Ciências e Educação, 2022; 8(4): 330-340.

Apaydin EA, Maher AR, Shanman R, Booth MS, Miles JN, Sorbero ME, Hempel SA systematic review of St. John’s wort for major depressive disorder. Systematic reviews, 2017; 5(1): 1-25.

Moreno RA, Teng CT, Almeida KMD, Tavares Junior H. Hypericum perforatum versus fluoxetine in the treatment of mild to moderate depression: a randomized double-blind trial in a Brazilian sample. Brazilian Journal of Psychiatry, 2017; 28(1): 29-32.

Ng QX, Venkatanarayanan N, Ho CYX. Clinical use of Hypericum perforatum (St John's wort) in depression: A meta-analysis. Journal of affective disorders, 2017; 1(210): 211-221.

Soleymani S, Bahramsoltani R, Rahimi R, Abdollahi M. Clinical risks of St John’s Wort (Hypericum perforatum) co-administration. Expert opinion on drug metabolism & toxicology, 2017; 13(10): 1047-1062.

Eatemadnia A, Ansari S, Abedi P, Najar S. The effect of Hypericum perforatum on postmenopausal symptoms and depression: A randomized controlled trial. Complementary therapies in medicine, 2019; 2(45): 109-113.

Zirak N, Shafiee M, Soltani G, Mirzaei M, Sahebkar A. Hypericum perforatum in the treatment of psychiatric and neurodegenerative disorders: Current evidence and potential mechanisms of action. Journal of cellular physiology, 2019; 234(6): 8496-8508.

Adibelli Z, Karacay I, Demir M, Duran C. St. John’s Wort (Hypericum perforatum)-Related Acute Kidney Injury. Blood Purification, 2022; 51(6): 520-522.

Published

2023-06-29

How to Cite

Chagas, A. L. S., Moura, H. G. Q., Sá, K. R. B. de, Nascimento, L. C. D., Guedes, L. C. P., Moura, P. G. P., & Cruz, T. K. da. (2023). Therapeutic applications of Hypericum perforatum (St. John’s wort) for treating anxiety and depression: integrative review. Annals of Olinda Medical School, 1(9), 55–63. https://doi.org/10.56102/afmo.2023.252

Issue

Section

Artigos de revisão integrativa, sistemática e metanálise